Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) Director Anna U. Loengard acquired 17,085 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The stock was purchased at an average cost of $0.96 per share, for a total transaction of $16,401.60. Following the completion of the purchase, the director […]